About Us
Bosnalijek is the largest industrial manufacturer of medicines in Bosnia and Herzegovina, established in 1951.
Our success is the result of deliberate strategy and joint efforts targeted at the company’s development.
Our success is the result of deliberate strategy and joint efforts targeted at the company’s development.
Press Centre
Bosnalijek is the largest industrial manufacturer of medicines in Bosnia and Herzegovina, established in 1951.
Our success is the result of deliberate strategy and joint efforts for the Company’s development.
Our success is the result of deliberate strategy and joint efforts for the Company’s development.
Our Pages
Language
News
PRESS CENTRE / NEWS
Two Bosnalijek Teams Won Valuable Prizes at Dolorex B2B Night Relay Race
Dolorex B2B night relay race, under a general sponsorship of Bosnalijek company, and Vienna Run4Lifestyle 10K Night Run, an international and socially responsible race, which opened the biggest festival of running in BiH “Olimpija Run Fest“, were held on Friday, 14 June 2019, in Sarajevo city center.
MORE
PRESS CENTRE / NEWS
Two Bosnalijek Teams Won Valuable Prizes at Dolorex B2B Night Relay Race
Dolorex B2B night relay race, under a general sponsorship of Bosnalijek company, and Vienna Run4Lifestyle 10K Night Run, an international and socially responsible race, which opened the biggest festival of running in BiH “Olimpija Run Fest“, were held on Friday, 14 June 2019, in Sarajevo city center.
Read more
ANNUAL REGULAR ASSEMBLY
Notice of convening annual regular assembly of Bosnalijek joint stock company
Pursuant to Article 230, paragraph (1) of Company Law (Official Gazette of FB&H, No. 81/15) and Article 48, paragraph (1) and (2) of valid Bosnalijek d.d. Statute (consolidated text No: 2830/2017 of 18.09.2017), and based on the Supervisory Board's Decision on Convening Annual Regular Assembly No: 1614/19 of 29.05.2019, we hereby announce:
Read more
Previous news
Professional Lecture for Doctors and Patients Held On the Occasion of th ...
Bosnalijek signs cooperation agreement with Mylan, a global healthcare c ...
Bosnalijek Appoints US Major General David L. Grange (Ret.) as the Board ...
The Third Congress of Pharmacists from Montenegro held in Bečići
Foreign markets recognize the quality of our products
Bosnalijek won the prestigious industry award
Bosnalijek is again the best employer in the pharmaceutical sector in 20 ...
Successful Two-Day Roundtable of Psychiatrists Held
“Global Enterofuryl® Speaker Training – GEST” conference gathers nationa ...
4th “Acute Coronary Syndrome” training for 60 young doctors
A successful year for Bosnalijek, revenue up by 10 percent
Third Generation of American Yale University Students Visits Bosnalijek
Notice of convening annual regular assembly of Bosnalijek joint stock co ...
Bosnalijek for the 21st Century
Postgraduate Students from the American University Yale visit Bosnalije ...
Bosnalijek achieves Record Turnover of 107 million BAM in Foreign Market ...
Memento – Little Dementia School
The First Regional Cardiology Case Report Award Competition (CCRAC 2017 ...
Continuous Growth: Bosnalijek Revenue increases by 35 per cent in 2017
Bosnalijek Wins Prestigious Award: Lysobact No. 1 in Sore Throat Remedie ...